Overcoming variable response in renal denervation: Key strategies for reliable clinical implementation.

While renal denervation (RDN) represents a promising therapy for resistant hypertension, substantial heterogeneity in blood pressure-lowering efficacy and a significant treatment non-response rate (reaching up to one-third of cases) impede its broade…

Preview only. Read the full abstract at the source